adamantane has been researched along with Reperfusion Injury in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 13 (81.25) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Abd El Fattah, MA; Abdallah, DM; El-Abhar, HS; Kamel, NM | 1 |
| Ahn, JH; Choi, KJ; Jung, WH; Kang, S; Kim, KY; Na, YJ; Nam, HJ; Park, SB | 1 |
| Beytur, A; Cakir, M; Erden, Y; Sandal, S; Taslıdere, A; Tekin, C; Tekin, S | 1 |
| Antonenko, V; Curato, C; Dwi Putra, SE; Falke, LG; Hasan, AA; Hocher, B; Klein, T; Mohagheghi Samarin, A; Reichetzeder, C; Rippmann, J; Tsuprykov, O; von Websky, K | 1 |
| Anderson, R; Bassi, R; Clark, J; De Nicola, GF; Eaton, P; Fernandez-Caggiano, M; Golforoush, PA; Hutchinson, JP; Kleinjung, J; Laing, A; Marber, MS; Martin, ED; Nichols, C; Thapa, D; Verma, S | 1 |
| Asfar, P; Collin, S; Fremont-Orlowski, S; Ganster, F; Issa, K; Kimmoun, A; Levy, B; Mertes, PM | 1 |
| Li, S; Li, Y; Wang, L; Wang, P; Wang, S; Zhang, L | 1 |
| Krishnasamy, Y; Lemasters, JJ; Liu, Q; Ramshesh, VK; Rehman, H; Schwartz, J; Shi, Y; Smith, CD; Zhang, X; Zhong, Z | 1 |
| Arni, S; Baerts, L; De Meester, I; Jungraithmayr, W; Matheeussen, V; Weder, W | 1 |
| Chang, SW; Chen, YZ; Fang, SY; Hsu, CY; Huang, CC; Lam, CF; Liu, YC; Roan, JN; Tsai, YC | 1 |
| Cho, JY; Kim, B; Kim, DK; Kim, YS; Lee, HY; Lee, JP; Lim, CS; Oh, YJ; Paik, JH; Yang, SH | 1 |
| Baerts, L; D'Haese, PC; De Beuf, A; De Meester, I; Glorie, LL; Hermans, N; Magielse, J; Matheeussen, V; Verhulst, A | 1 |
| Krishnasamy, Y; Lemasters, JJ; Liu, Q; Rehman, H; Shi, Y; Smith, CD; Zhong, Z | 1 |
| Aldinucci, C; Contartese, A; Corelli, F; Frosini, M; Mugnaini, C; Pasquini, S; Pessina, F; Sgaragli, G; Valoti, M | 1 |
| Galun, E; Matot, I; Rivo, J; Zeira, E | 1 |
| Bucolo, C; Caputi, A; Cuzzocrea, S; Drago, F; Marrazzo, A; Mazzon, E; Ronsisvalle, G; Ronsisvalle, S | 1 |
16 other study(ies) available for adamantane and Reperfusion Injury
| Article | Year |
|---|---|
Novel repair mechanisms in a renal ischaemia/reperfusion model: Subsequent saxagliptin treatment modulates the pro-angiogenic GLP-1/cAMP/VEGF, ANP/eNOS/NO, SDF-1α/CXCR4, and Kim-1/STAT3/HIF-1α/VEGF/eNOS pathways.
Topics: Adamantane; Animals; Atrial Natriuretic Factor; Cell Adhesion Molecules; Chemokine CXCL12; Cyclic AMP; Dipeptides; Disease Models, Animal; Glucagon-Like Peptide 1; Glutathione; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney; Male; Malondialdehyde; Neovascularization, Physiologic; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; Receptors, CXCR4; Reperfusion Injury; Signal Transduction; STAT3 Transcription Factor; Vascular Endothelial Growth Factor A | 2019 |
Protective effect of a novel selective 11β-HSD1 inhibitor on eye ischemia-reperfusion induced glaucoma.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adamantane; Animals; Carbenoxolone; Eye; Glaucoma; Intraocular Pressure; Male; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Glucocorticoid; Reperfusion Injury; Thiadiazines; Trabecular Meshwork | 2019 |
Protective effect of saxagliptin against renal ischaemia reperfusion injury in rats.
Topics: Adamantane; Animals; Dipeptides; Kidney; Kidney Diseases; Rats; Reperfusion Injury | 2022 |
Head-to-head comparison of structurally unrelated dipeptidyl peptidase 4 inhibitors in the setting of renal ischemia reperfusion injury.
Topics: Adamantane; Animals; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Kidney; Linagliptin; Male; Molecular Structure; Nitriles; Pyrrolidines; Rats; Rats, Wistar; Reperfusion Injury; Sitagliptin Phosphate; Structure-Activity Relationship; Vildagliptin | 2017 |
The TAB1-p38α complex aggravates myocardial injury and can be targeted by small molecules.
Topics: Adamantane; Adaptor Proteins, Signal Transducing; Animals; Cell Line; Crystallography, X-Ray; Disease Models, Animal; Female; Gene Knock-In Techniques; HEK293 Cells; Humans; Male; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinase 14; Mutation; Myocardial Infarction; Myocardium; Phosphorylation; Protein Binding; Protein Interaction Domains and Motifs; Reperfusion Injury | 2018 |
Compared effects of inhibition and exogenous administration of hydrogen sulphide in ischaemia-reperfusion injury.
Topics: Acidosis, Lactic; Adamantane; Adenosine Triphosphate; Alkynes; Animals; Cytokines; Disease Models, Animal; Gasotransmitters; Glycine; Hemodynamics; Hydrogen Sulfide; KATP Channels; Male; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; Morpholines; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Norepinephrine; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats, Wistar; Reperfusion Injury; Shock, Hemorrhagic; Sulfides; Up-Regulation; Vasoconstrictor Agents | 2013 |
Effects of calcium-sensing receptors on apoptosis in rat hippocampus during hypoxia/reoxygenation through the ERK1/2 pathway.
Topics: Adamantane; Animals; Apoptosis; Apoptosis Regulatory Proteins; Cell Proliferation; Cell Survival; Cells, Cultured; Female; Gadolinium; Hippocampus; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neurons; Phosphorylation; Quinoxalines; Rats, Wistar; Receptors, Calcium-Sensing; Reperfusion Injury; Signal Transduction; Time Factors | 2015 |
Sphingosine kinase-2 inhibition improves mitochondrial function and survival after hepatic ischemia-reperfusion.
Topics: Adamantane; Animals; Cell Death; Enzyme Inhibitors; Gene Knockdown Techniques; Hepatocytes; In Vitro Techniques; Inflammation; Liver; Lysophospholipids; Male; Mice; Mitochondria, Liver; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Nitric Oxide Synthase Type II; Phosphotransferases (Alcohol Group Acceptor); Pyridines; Reperfusion Injury; RNA, Messenger; RNA, Small Interfering; Sphingosine | 2012 |
CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation.
Topics: Adamantane; Animals; Antigens, CD34; Chemokine CXCL12; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Drug Evaluation, Preclinical; Hematopoietic Stem Cells; Injections, Subcutaneous; Lung; Lung Transplantation; Male; Mice; Mice, Inbred C57BL; Nitriles; Pyrrolidines; Receptors, CXCR4; Reperfusion Injury; Vildagliptin | 2012 |
Cardiovascular protection of activating KATP channel during ischemia-reperfusion acidosis.
Topics: Acidosis; Adamantane; Animals; Aorta, Abdominal; Calcium; Dose-Response Relationship, Drug; Glyburide; Hemodynamics; KATP Channels; Morpholines; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tissue Culture Techniques; Vasodilation | 2012 |
Soluble epoxide hydrolase activity determines the severity of ischemia-reperfusion injury in kidney.
Topics: Adamantane; Animals; Cell Movement; Cytokines; Endothelial Cells; Epoxide Hydrolases; Kidney; Lauric Acids; Male; Mice; Neovascularization, Physiologic; Reperfusion Injury; Severity of Illness Index | 2012 |
DPP4 inhibition improves functional outcome after renal ischemia-reperfusion injury.
Topics: Adamantane; Animals; Apoptosis; Blood Glucose; Creatinine; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Kidney; Kidney Tubules; Male; Nitriles; Oxidative Stress; Pyrrolidines; Rats; Reperfusion Injury; Vildagliptin | 2012 |
Inhibition of sphingosine kinase-2 suppresses inflammation and attenuates graft injury after liver transplantation in rats.
Topics: Adamantane; Animals; Cell Adhesion Molecules; Chemokines; Enzyme Inhibitors; Inflammation; Leukocytes; Liver; Liver Transplantation; Lysophospholipids; Male; NF-kappa B; Phosphotransferases (Alcohol Group Acceptor); Pyridines; Rats; Rats, Inbred Lew; Reactive Oxygen Species; Reperfusion Injury; Sphingosine; Toll-Like Receptor 4; Up-Regulation | 2012 |
A novel CB2 agonist, COR167, potently protects rat brain cortical slices against OGD and reperfusion injury.
Topics: Adamantane; Animals; Cannabinoid Receptor Agonists; Cerebral Cortex; Glucose; Glutamic Acid; Interleukin-6; L-Lactate Dehydrogenase; Male; Molecular Structure; Oxygen; Quinolones; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB2; Reperfusion Injury; Tissue Culture Techniques; Tumor Necrosis Factor-alpha; Water | 2012 |
Activation of A3 adenosine receptors attenuates lung injury after in vivo reperfusion.
Topics: Adamantane; Adenosine; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Animals; ATP-Binding Cassette Transporters; Cats; Dihydropyridines; Enzyme Inhibitors; Hemodynamics; Histamine; In Vitro Techniques; KATP Channels; Lung; Morpholines; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroarginine; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Inwardly Rectifying; Pulmonary Artery; Reperfusion Injury | 2004 |
A novel adamantane derivative attenuates retinal ischemia-reperfusion damage in the rat retina through sigma1 receptors.
Topics: Adamantane; Adenosine Triphosphate; Animals; Anisoles; Glucose; Lactic Acid; Male; Propylamines; Rats; Rats, Sprague-Dawley; Receptors, sigma; Reperfusion Injury; Retina; Retinal Diseases | 2006 |